HEALTHY VOLUNTEERS (HV)
Clinical trials for HEALTHY VOLUNTEERS (HV) explained in plain language.
Never miss a new study
Get alerted when new HEALTHY VOLUNTEERS (HV) trials appear
Sign up with your email to follow new studies for HEALTHY VOLUNTEERS (HV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Parkinson's drug enters first human safety trials
Symptom relief Recruiting nowThis study tests whether a new oral drug, AX-5006, is safe and tolerable in healthy adults and people with Parkinson's disease. It involves three parts: single doses, multiple doses over a week, and daily doses for 28 days. The goal is to gather safety data before larger trials.
Matched conditions: HEALTHY VOLUNTEERS (HV)
Phase: PHASE1 • Sponsor: Vertero Therapeutics • Aim: Symptom relief
Last updated May 17, 2026 04:17 UTC
-
New drug HXN6005 enters first human safety tests
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug, HXN6005, in 32 healthy adults to see if it is safe and how the body processes it. Participants receive a single dose of either the drug or a placebo and are monitored for side effects and drug levels. The goal is to gather safety info…
Matched conditions: HEALTHY VOLUNTEERS (HV)
Phase: PHASE1 • Sponsor: Helixon Biotechnology (Suzhou) Co., Ltd • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC